https://www.selleckchem.com/pr....oducts/hpk1-in-2.htm
This allowed us to identify five broad policy categories for subsequent analysis national laws, national regulations, health system incorporation of rare disease treatments, care delivery, and patient engagement.By describing the different approaches, challenges and timelines across six countries, our research demonstrates that strengthening rare disease policy first requires a common understanding and local consensus of each country's recent past and current situation. Subsequent analysis based on a set of common policy dimensions le
Like
Comment
Share
